Dérivés de Quinazoline et de Quinoléine
Les quinazolines et les quinoléines sont des composés hétérocycliques azotés à structure aromatique qui jouent un rôle clé dans la synthèse de médicaments à activité anticancéreuse, antimicrobienne et anti-inflammatoire. Leurs dérivés présentent des modifications structurelles qui optimisent leur biodisponibilité et leur sélectivité, permettant ainsi le développement de nouveaux principes actifs pour diverses applications thérapeutiques. Ces composés sont utilisés dans la fabrication d’API destinés au traitement du cancer, des infections, des maladies neurodégénératives et cardiovasculaires. De plus, les dérivés de quinazoline et de quinoléine sont essentiels dans la recherche d’inhibiteurs enzymatiques et dans la conception de molécules bioactives innovantes.
Chez CymitQuimica, nous proposons des dérivés de quinazoline et de quinoléine de haute pureté pour des applications en synthèse chimique, développement pharmaceutique et biotechnologie.
65630 produits trouvés pour "Dérivés de Quinazoline et de Quinoléine"
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
Ambrisentan Related Compound D (2-[(2,2-Diphenylvinyl)oxy]-4,6-dimethylpyrimidine)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C20H18N2OCouleur et forme :Off-White Fine PowderMasse moléculaire :302.14191Ofloxacin
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C18H20FN3O4Couleur et forme :Off-White Pale Yellow PowderMasse moléculaire :361.14378Darunavir Ethanolate
CAS :Sulfonamides used as drugsFormule :C27H37N3O7S·C2H6OCouleur et forme :White Beige PowderMasse moléculaire :593.27709Fluvoxamine Maleamide (13-oxo-7-(4-(trifluoromethyl)phenyl)-2,9-dioxa-8,12-diazahexadeca-7,14-dien-16-oic acid)
CAS :Aromatic organic derivatives of hydrazine or of hydroxylamineFormule :C19H23F3N2O5Couleur et forme :Off-White SolidMasse moléculaire :416.15591Metoprolol Tartrate
CAS :Aromatic drugs of amino-alcohols, other than those contg more than one kind of oxygen function, their ethers and esters; salts thereof, nesoiFormule :C15H25NO3C4H6O6Couleur et forme :White Crystalline PowderMasse moléculaire :684.81Plerixafor System Suitability Mixture
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiCouleur et forme :White Off-White SolidAmbrisentan
CAS :Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureFormule :C22H22N2O4Couleur et forme :White Light Yellow Crystalline PowderMasse moléculaire :378.15796Fluphenazine Enanthate Dihydrochloride
CAS :Antidepressants, tranquilizers and other pschotherapeutic agentsFormule :C29H38F3N3O2S·2HClCouleur et forme :PowderMasse moléculaire :549.26368Silodosin S-Enantiomer
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C25H32F3N3O4Couleur et forme :White Off-White Crystalline PowderMasse moléculaire :495.23449Prasugrel Related Compound D (5-[2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-5,6,7,7a-tetrahydrothieno[3,2-c]pyridin-2(4H)-one)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C18H18FNO2SCouleur et forme :Off-White PowderMasse moléculaire :331.10423Everolimus
CAS :Antibiotics nesoiFormule :C53H83NO14Couleur et forme :White Yellow PowderMasse moléculaire :957.58136Paroxetine Related Compound C ((3R,4S)-3-[(Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride) OR ((+)-trans-Paroxetine hydrochloride)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C19H20FNO3·HClCouleur et forme :White PowderMasse moléculaire :365.1194Paliperidone Related Compound E (3-{2-[4-(6-Fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-7,8-dihydro-4H-pyrido[1,2-a]pyrimidine-4,9(6H)-dione trifluoroacetate)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C23H25FN4O3·C2HF3O2Couleur et forme :Yellow PowderMasse moléculaire :424.19107Naproxen Sodium
CAS :Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc, nesoiFormule :C14H13NaO3Couleur et forme :White Cream PowderMasse moléculaire :252.07624Levetiracetam Racemic Mixture (1:1 mixture of levetiracetam S-enantiomer-(2S)-2-(2-oxopyrrolidin-1-yl)butanamide and levetiracetam R-enantiomer (2R)-2-(2-oxopyrrolidin-1-yl)butanamide)
CAS :Lactams, nesoiFormule :C8H14N2O2Couleur et forme :White Off-White PowderMasse moléculaire :170.10553Paroxetine Hydrochloride
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C19H20FNO3·HClH2OCouleur et forme :White Off-White Crystalline PowderMasse moléculaire :329.14272Crospovidone
CAS :Other vinyl polymers in primary forms,nesoiFormule :(C6H9NO)nCouleur et forme :White Off-White PowderMasse moléculaire :177.121Ondansetron Hydrochloride
CAS :Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFormule :C18H19N3O·HCl·2H2OCouleur et forme :White Off-White PowderMasse moléculaire :293.15281Celecoxib Open Ring (4-((1,1,1-trifluoro-4-hydroxy-4-(p-tolyl)but-3-en-2-ylidene)amino)benzenesulfonamide)
Sulfonamides, nesoiFormule :C17H15F3N2O3SCouleur et forme :Yellow SolidMasse moléculaire :384.07555Aripiprazole 4,4'-dimer (7,7'-((((ethane-1,1-diylbis(2,3-dichloro-4,1-phenylene))bis(piperazine-4,1-diyl))bis(butane-4,1-diyl))bis(oxy))bis(3,4-dihydroquinolin-2(1H)-one)
CAS :Lactams, nesoiFormule :C48H56Cl4N6O4Couleur et forme :White Off-White SolidMasse moléculaire :920.31172Methylisoindolinedione (2-methylisoindoline-1,3-dione)
CAS :Imides and their derivatives (excluding sacharin), and salts thereofFormule :C9H7NO2Couleur et forme :White Off-White SolidMasse moléculaire :161.04768Erlotinib Related Compound A (4-(3-{[6,7-Bis(2-methoxyethoxy) quinazolin-4-yl]amino}phenyl)-2-methyl-3-butyn-2-ol hydrochloride)
CAS :Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormule :C25H29N3O5·HClCouleur et forme :Off-White PowderMasse moléculaire :451.21072Desimidazoline Sunitinib (5-Formyl-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, excluding aromatic or modified aromaticFormule :C14H23N3O2Couleur et forme :White Off-White PowderMasse moléculaire :265.17903Rivaroxaban Ethyl Carbamate (ethyl (4-(3-oxomorpholino)phenyl)carbamate)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C13H16N2O4Couleur et forme :White Off-White SolidMasse moléculaire :264.11101Oxcarbazepine
CAS :Anticonvulsants, hypnotics and sedativesFormule :C15H12N2O2Couleur et forme :Off-White Cream Light Orange PowderMasse moléculaire :252.089882,4-Disulfamyl-5-Trifluoromethylaniline
CAS :Sulfonamides, nesoiFormule :C7H8F3N3O4S2Couleur et forme :PowderMasse moléculaire :318.99083O-Thienylethyl Rotigotine Hydrochloride ((S)-N-propyl-5-(2-(thiophen-2-yl)ethoxy)-N-(2-(thiophen-2-yl)ethyl)-1,2,3,4-tetrahydronaphthalen-2-amine hydrochloride)
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C25H32ClNOS2Couleur et forme :Pale Beige SolidMasse moléculaire :461.16138Desiodoamiodarone ((2-butylbenzofuran-3-yl)(4-(2-(diethylamino)ethoxy)phenyl)methanone)
CAS :Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormule :C25H31NO3Couleur et forme :Colorless LiquidMasse moléculaire :393.23039Omeprazole Magnesium
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C34H36MgN6O6S2Couleur et forme :White Off-White PowderMasse moléculaire :712.19882Dofetilide Related Compound B (N-Methyl-N-[4-(methylsulfonamido)phenethyl]-2-[4-(methylsulfonamido)phenoxy]ethan-1-amine oxide)
CAS :Sulfonamides, nesoiFormule :C19H27N3O6S2Couleur et forme :Off-White PowderMasse moléculaire :457.13413Omeprazole Related Compound E (4-Methoxy-2-[[(RS)-(5-methoxy-1H-benzimidazol-2-yl)sulfinyl]methyl]-3,5-dimethylpyridine 1-oxide)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C17H19N3O4SCouleur et forme :Off-White PowderMasse moléculaire :361.10963Bendroflumethiazide
CAS :Sulfonamides used as drugsFormule :C15H14F3N3O4S2Couleur et forme :PowderMasse moléculaire :421.42Atazanavir Sulfate
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C38H52N6O7·H2SO4Couleur et forme :White Pale Yellow PowderMasse moléculaire :802.35713Deschlorosorafenib (N-Methyl-4-[4-[[[[3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-2-pyridinecarboxamide; N-Methyl-4-{4-[3-(3-trifluoromethylphenyl)ureido]phenoxy}picolinamide)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C21H17F3N4O3Couleur et forme :White Off-White SolidMasse moléculaire :430.12527Sildenafil Citrate
CAS :Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureFormule :C22H30N6O4S·C6H8O7Couleur et forme :White Off-White Crystalline PowderMasse moléculaire :474.20492Dabigatran Etexilate Related Compound A (Ethyl 3-(2-{[(4-{[(hexyloxy)carbonyl]carbamoyl}phenyl)amino]methyl}-1-methyl-N-(pyridin-2-yl)-1H-benzimidazole-5-carboxamido)propanoate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C34H40N6O6Couleur et forme :White SolidMasse moléculaire :628.30093Iodoquinol
CAS :Drugs containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) not further fusedFormule :C9H5I2NOCouleur et forme :Light Brown Yellow PowderMasse moléculaire :396.84606Rivaroxaban isomer (4-(4-(((2-(5-chlorothiophen-2-yl)-4,5-dihydrooxazol-5-yl)methyl)amino)phenyl)morpholin-3-one)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C18H18ClN3O3SCouleur et forme :White Off-White SolidMasse moléculaire :391.07574Ambrisentan Related Compound B (2-Hydroxy-3-methoxy-3,3-diphenylpropanoic acid)
CAS :Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc, nesoiFormule :C16H16O4Couleur et forme :Off-White PowderMasse moléculaire :272.104862-Vinylpyridine (2-Ethenylpyridine)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C7H7NCouleur et forme :Light Brown LiquidMasse moléculaire :105.05785Clozapine Resolution Mixture
CAS :Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureCouleur et forme :Yellow Crystalline PowderMasse moléculaire :203.09061Chlorothiophene Aldehyde (5-chlorothiophene-2-carbaldehyde)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C5H3ClOSCouleur et forme :Brown LiquidMasse moléculaire :145.95931Nadolol Related Compound A ((2RS,3SR)-5-(2,3-Dihydroxypropoxy)-1,2,3,4-tetrahydronaphthalene-2,3-diol)
CAS :Ether-phenols, ether-alcohol-phenols and their halogenated, sulfonated, nitrated or nitrosated derivativesFormule :C13H18O5Couleur et forme :White SolidMasse moléculaire :254.11542Mirabegron Racemate
CAS :Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFormule :C21H24N4O2SCouleur et forme :White PowderMasse moléculaire :396.162o-Celecoxib (4-(5-(o-tolyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide)
CAS :Sulfonamides, nesoiFormule :C17H14F3N3O2SCouleur et forme :White Off-White SolidMasse moléculaire :381.07588Salmeterol Related Compound A (4-[1-Hydroxy-2-(4-phenylbutylamino)ethyl]-2-(hydroxymethyl)phenol 1-hydroxy-2-naphthoate)
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C19H25NO3·C11H8O3Couleur et forme :White PowderMasse moléculaire :315.18344Rotigotine Related Compound H ((S)-5-Methoxy-N-propyl-N-[2-(thiophen-2-yl)ethyl]-1,2,3,4-tetrahydronaphthalen-2-amine)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C20H27NOSCouleur et forme :Light Brown LiquidMasse moléculaire :329.18134Labetalol Cyclohexyl Analog (5-{2-[(4-Cyclohexylbutan-2-yl)amino]-1-hydroxyethyl}-2-hydroxybenzamide hydrochloride)
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C19H30N2O3·HClCouleur et forme :White PowderMasse moléculaire :370.20232Rivaroxaban Amine ((S)-4-(4-(5-(aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one, hydrochloride)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C14H17N3O4·HClCouleur et forme :Off-White SolidMasse moléculaire :327.09858Salmeterol Related Compound H (1-Hydroxy-4-[2-hydroxy-5-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)benzyl]-2-naphthoic acid, monohydrate)
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C36H43NO6·H2OCouleur et forme :White SolidMasse moléculaire :603.3196
![Salmeterol Related Compound A (4-[1-Hydroxy-2-(4-phenylbutylamino)ethyl]-2-(hydroxymethyl)phenol 1…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1609614.webp&w=3840&q=75)